Author

A. Ajei

Institutions: Mayo Clinic, National Cancer Institute

Observed institutions: Mayo Clinic, National Cancer Institute

OpenAlex ID: A5016826899

A phase I trial of 17-allylamino-geldanamycin (17AAG) in patients with advanced cancer

2004 · C. Erlichman, D. Toft, et al. · Journal of Clinical Oncology · 16

Works count: 1

Citation count: 16

H-index: 1

I10-index: 1